Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis (MaSep)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by Universitätsmedizin Mannheim
Sponsor:
Information provided by (Responsible Party):
Dr. med. Ursula Hoffmann, Universitätsmedizin Mannheim
ClinicalTrials.gov Identifier:
NCT01535534
First received: February 14, 2012
Last updated: May 9, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):